HIGHLIGHTS
- who: Tingze Feng from the National Cancer Institute (NIH), United States Yogi Vemana University, India have published the paper: Stemness Analysis Uncovers That The Peroxisome Proliferator-Activated Receptor Signaling Pathway Can Mediate Fatty Acid Homeostasis In Sorafenib-Resistant Hepatocellular Carcinoma Cells, in the Journal: (JOURNAL)
- what: Based on the results of the study , the authors thought that, in addition to commonly reported pathways, PPAR-related activities associated with fatty_acid metabolism might also affect the response to sorafenib treatment.
- how: In total the authors obtained seven HCC cohorts involving a total of 991 samples . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.